Asthma exacerbation reductions similar across seasons with dupilumab

Patients with type 2 inflammation experienced reductions in asthma exacerbations with dupilumab, with no differences between seasons, according to a study published in Annals of Allergy, Asthma & Immunology.
Patients experienced these reductions regardless of whether they had or did not have evidence of allergic asthma as well, Anju T. Peters, MD, professor, departments of medicine and otolaryngology head and neck surgery, Northwestern University Feinberg School of Medicine, and colleagues wrote.
The post-hoc analysis examined data from the LIBERTY ASTHMA QUEST study, where patients aged 12

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart